{"slug":"ss-31-trigeminal","verification":{"valid":true,"entries":2,"head":"71b05dd73ff02612d0f9df94557a5b5091230e0558f7f84f0e51930a2f147460"},"energy":{"passes":2,"tokens_in":22314,"tokens_out":2799,"tokens_total":25113,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"71b05dd73ff02612d0f9df94557a5b5091230e0558f7f84f0e51930a2f147460"},"provenance":[{"ts":"2026-06-29T23:45:01.708Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Ss 31 for Trigeminal\nSlug: ss-31-trigeminal\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"ss-31\",\"name\":\"SS-31 (Elamipretide)\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"ss-31\",\"name\":\"SS-31 (Elamipretide)\",\"section_title\":\"Why SS-31 (Elamipretide) might help you\",\"layer\":\"mitochondrial\",\"steps\":[\"**Therefore for you:** If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. **Therefore for you:** If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **SS-31 (Elamipretide)** → mitochondrial\",\"section_headings\":[\"What's breaking down\",\"Why SS-31 (Elamipretide) might help you\",\"How these fit together\",\"What the evidence actually shows\",\"What scientists say\",\"What people say on Reddit\",\"What people say on X\",\"What we do not know\",\"Safety and limits\"],\"writer_rules\":[\"One ## section per compound in peptide_chains — do not ","response":"{\n  \"slug\": \"ss-31-trigeminal\",\n  \"title\": \"SS-31 (Elamipretide) for Trigeminal Issues: Mitochondrial Repair Evidence\",\n  \"body\": \"## What's breaking down\\n\\nTrigeminal conditions often involve the trigeminal nerve and its central processing in the trigeminal nucleus caudalis (TNC) in the brainstem. One key degenerative layer is mitochondrial dysfunction inside neurons and glia there. Mitochondria produce ATP for nerve signaling and maintenance. When they falter, reactive oxygen species rise, energy drops, and cells struggle to repair damage or dampen overactive pain pathways. This can sustain neuropathic pain or headache-like responses even after initial triggers fade. Repair pathways that restore mitochondrial membrane integrity and electron transport could slow this breakdown. Symptom suppression alone leaves the energy deficit unaddressed.\\n\\n## Why SS-31 (Elamipretide) might help you\\n\\nIf mitochondrial impairment in the TNC is part of your trigeminal picture, SS-31 targets that layer directly. It binds cardiolipin in the inner mitochondrial membrane. This stabilizes the membrane, supports efficient electron transport, and cuts excess ROS production. The result is better ATP output and less oxidative stress on nerve cells. In a mouse model of repeated inflammatory soup infusion that mimics aspects of headache and affects the TNC, SS-31 reversed mitochondrial ultrastructure damage, restored homeostasis markers, and reduced nociceptive behaviors. The study linked this to a Sirt3/PGC-1α feedback loop that supports mitochondrial biogenesis. Therefore, if your symptoms trace to energy-starved trigeminal neurons, SS-31 is discussed for its studied role in tissue-level mitochondrial repair rather than masking pain signals.\\n\\n## How these fit together\\n\\nSingle-compound focus. SS-31 addresses the mitochondrial layer. If your profile includes other degeneration layers, separate compounds would target those without overlap in mechanism here.\\n\\n## What the evidence actu","tokens_in":22314,"tokens_out":2799,"cost":0,"prev":"genesis","hash":"8835fb8de5b0d44b4ef14d18923d912361f752d1c909cbd5cc4cab2ebc02da1c"},{"ts":"2026-07-17T02:42:10.995Z","model":"owner","action":"voxel_divide","prompt":"","input":"ss-31-trigeminal","response":"18 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"8835fb8de5b0d44b4ef14d18923d912361f752d1c909cbd5cc4cab2ebc02da1c","hash":"71b05dd73ff02612d0f9df94557a5b5091230e0558f7f84f0e51930a2f147460"}]}